title: Penicillamine revisited: historic overview and review of the clinical uses and cutaneous adverse effects.
abstract: Penicillamine is a well-known heavy metal chelator, classically used in the treatment of Wilson disease, rheumatoid arthritis, and cystinuria. From a dermatologic standpoint, penicillamine was found to be useful in the treatment of systemic sclerosis. The successful therapeutic uses of penicillamine have been hindered by its numerous adverse effects, both cutaneous and extra-cutaneous. It is a unique drug since it provokes a diversity of dermatologic manifestations that include (1) acute hypersensitivity reactions, (2) dermopathies characterized by elastic fiber abnormalities including elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum, (3) autoimmune disorders such as pemphigus and penicillamine-induced lupus erythematosus-like syndrome, and (4) miscellaneous dermatoses that result from undefined mechanisms. These cutaneous adverse effects may correlate with the dosage and duration of penicillamine therapy as well as the disease being treated.
authors.affiliation: Department of Dermatology, American University of Beirut Medical Center, Riad El Solh/Beirut, P.O. Box 11-0236, Beirut 1107 2020, Lebanon.
authors.forename: Rim
authors.initials: R
authors.lastname: Ishak
authors.forename: Ossama
authors.initials: O
authors.lastname: Abbas
mesh_terms: D002614:Chelating Agents / Q000009:adverse effects*; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced*
chemical_list: D002614:Chelating Agents; D010396:Penicillamine